Total Payments
$231.48
2022 Payments
$11.79
Companies
7
Transactions
17
Medicare Patients
3,134
Medicare Billing
$582,621
Payment Breakdown by Category
Food & Beverage$231.48 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $231.48 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $66.06 | 6 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $60.94 | 4 | $0 (2019) |
| PORTOLA PHARMACEUTICALS, INC. | $30.65 | 2 | $0 (2019) |
| CSL Behring | $26.35 | 2 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.00 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $14.91 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $14.57 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $11.79 | 1 | CSL Behring ($11.79) |
| 2021 | $14.91 | 1 | AstraZeneca Pharmaceuticals LP ($14.91) |
| 2019 | $59.77 | 4 | PORTOLA PHARMACEUTICALS, INC. ($30.65) |
| 2018 | $42.82 | 3 | Janssen Pharmaceuticals, Inc ($28.25) |
| 2017 | $102.19 | 8 | Merck Sharp & Dohme Corporation ($66.06) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/12/2022 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 01/22/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/16/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $14.51 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 02/28/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $16.14 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 02/21/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2019 | CSL Behring | Kcentra (Biological) | Food and Beverage | Cash or cash equivalent | $14.56 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 06/18/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/06/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/05/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/07/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), PRAXBIND | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/03/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/18/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/25/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/16/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/24/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 655 | 1,394 | $209,904 | $131,162 |
| 2022 | 8 | 781 | 1,629 | $241,475 | $148,436 |
| 2021 | 10 | 838 | 1,566 | $233,763 | $147,027 |
| 2020 | 9 | 860 | 1,735 | $251,140 | $155,997 |
Total Patients
3,134
Total Services
6,324
Medicare Billing
$582,621
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 180 | 252 | $69,854 | $37,390 | 53.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 126 | 351 | $49,386 | $34,090 | 69.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 149 | 519 | $50,680 | $33,735 | 66.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 200 | 272 | $39,984 | $25,946 | 64.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 177 | 672 | $65,621 | $41,543 | 63.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 188 | 248 | $68,746 | $41,195 | 59.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 127 | 351 | $49,386 | $31,095 | 63.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 182 | 233 | $34,251 | $20,812 | 60.8% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 38 | 47 | $11,943 | $7,006 | 58.7% |
| 99236 | Hospital observation or inpatient care admitted and discharged on the same day for high severity problem, typically 55 minutes | Facility | 2022 | 14 | 14 | $4,131 | $2,481 | 60.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 39 | 41 | $4,090 | $2,357 | 57.6% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 16 | 23 | $3,309 | $1,946 | 58.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 180 | 228 | $63,202 | $39,059 | 61.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 172 | 593 | $57,906 | $36,994 | 63.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 132 | 306 | $43,054 | $27,425 | 63.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 185 | 238 | $34,986 | $21,969 | 62.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 51 | 53 | $13,467 | $8,219 | 61.0% |
| 99236 | Hospital observation or inpatient care high severity, 55 minutes per day | Facility | 2021 | 36 | 37 | $10,917 | $6,289 | 57.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 47 | $4,442 | $3,497 | 78.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 30 | 30 | $2,993 | $1,853 | 61.9% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 12 | 13 | $1,870 | $1,141 | 61.0% |
| 98925 | Osteopathic manipulative treatment to 1-2 body regions | Office | 2021 | 12 | 21 | $926.10 | $582.96 | 62.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 189 | 788 | $76,998 | $48,849 | 63.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 169 | 206 | $57,103 | $34,686 | 60.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 138 | 316 | $44,461 | $28,030 | 63.0% |
About Dr. Christopher Bader, D.O
Dr. Christopher Bader, D.O is a Hospitalist healthcare provider based in Brick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2008. The National Provider Identifier (NPI) number assigned to this provider is 1447406913.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Bader, D.O has received a total of $231.48 in payments from pharmaceutical and medical device companies, with $11.79 received in 2022. These payments were reported across 17 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($231.48).
As a Medicare-enrolled provider, Bader has provided services to 3,134 Medicare beneficiaries, totaling 6,324 services with total Medicare billing of $582,621. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Family Medicine
- Location Brick, NJ
- Active Since 08/14/2008
- Last Updated 07/12/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447406913
Products in Payments
- XARELTO (Drug) $60.94
- JANUVIA (Drug) $43.66
- ANDEXXA (Biological) $30.65
- Kcentra (Biological) $26.35
- ZERBAXA (Drug) $22.40
- PRADAXA (Drug) $18.00
- LOKELMA (Drug) $14.91
- ENTRESTO (Drug) $14.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.